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Abstract: 
XRCC4 and XLF are two structurally-related proteins that function in DNA double-strand break 
(DSB) repair. Here, we identify human PAXX (PAralog of XRCC4 and XLF; also called 
C9orf142) as a new XRCC4-superfamily member, and show that its crystal structure resembles 
that of XRCC4. PAXX interacts directly with the DSB-repair protein Ku and is recruited to 
DNA-damage sites in cells. Using RNA interference and CRISPR-Cas9 to generate PAXX-/- 
cells, we demonstrate that PAXX functions with XRCC4 and XLF to mediate DSB repair and 
cell survival in response to DSB-inducing agents. Finally, we reveal that PAXX promotes Ku-
dependent DNA ligation in vitro, and assembly of core non-homologous end-joining (NHEJ) 
factors on damaged chromatin in cells. These findings identify PAXX as a new component of the 
NHEJ machinery. 
 
One Sentence Summary: PAXX, a paralog of XRCC4, promotes DNA double-strand break 
repair. 
  
Main Text: 
DNA double-strand breaks (DSBs) are toxic lesions that arise in cells exposed to agents such as 
ionizing radiation (IR), and are also generated as intermediates during V(D)J (variable, diversity, 
joining) and class-switch recombination at immune-receptor gene loci (1). If unrepaired or 
repaired incorrectly, DSBs cause cell death or genome instability, and defects in DSB repair 
components cause hereditary disorders with symptoms including immunodeficiency, 
neurodegeneration, infertility and/or increased cancer predisposition (2). A key DNA repair 
pathway is non-homologous end-joining (NHEJ), which involves initial recognition of a DSB by 
the Ku70-Ku80 heterodimer followed by the assembly of additional factors including the DNA-
dependent protein kinase catalytic subunit (DNA-PKcs), X-ray cross-complementing protein 4 
(XRCC4) and XRCC4-like factor (XLF; also called Cernunnos), with XRCC4 playing a prime 
role in recruiting DNA ligase IV (LIG4) to carry out the DSB-joining reaction (3). 
 
XRCC4 and XLF, together with spindle-assembly abnormal protein 6 (SAS6), comprise a 
homologous superfamily of structurally-related proteins (4). To identify other members of this 
protein superfamily, we used a bioinformatics approach, which suggested that the 22-kDa human 
protein, C9orf142, could be an XRCC4 paralog (Table S1 and S2). While displaying little overall 
primary sequence similarity, sequence alignments indicated that the N-terminal portion of 
C9orf142 contains the present-in-SAS6 (PISA) motif that is conserved throughout the XRCC4 
superfamily (5), and shares a conserved tryptophan in this motif with XRCC4 and XLF (Fig. 1A 
and Fig. S1A). We have therefore named this previously uncharacterized protein PAXX 
(PAralog of XRCC4 and XLF). While having a wide evolutionary distribution (Fig. S1B), we 
could not identify PAXX orthologs in insects or fungi. 
 
We solved crystal structures of PAXX residues 1-145, 1-166 and the full-length protein (PAXX1-
145, PAXX1-166 and PAXX1-204) at resolutions of 2.46, 2.35 and 3.45 Å respectively (Table S3). 
PAXX residues 1-113 form a head domain that is structurally closely related to those of XRCC4, 
XLF and SAS6 (6–11) (Fig. 1, A and B). This is followed by a 31-amino-acid α-helix, forming a 
coiled-coil with the other protomer to make a PAXX homodimer (in the asymmetric unit) in a 
similar manner to the dimeric interfaces formed by XRCC4, XLF and SAS6. Contacts within the 
PAXX crystal indicate that the protein has potential to form higher-order protein filaments with 
similarities to those of its paralogs (Fig. S2A), in which two β-sheets, each comprising strands 
β5-β7 from different PAXX dimers, form a β-sandwich around a dyad axis running between the 
sheets and orthogonally to the strands (Fig. 1C). However, small angle X-ray scattering (SAXS) 
data of PAXX1-145 in solution are well explained by the scattering curve calculated from the 
structure of the dimer of the construct (Fig. S2B), and electrospray mass spectroscopy confirmed 
that PAXX predominantly forms dimers in solution under the conditions used (Fig. 1D and Table 
S4). These data thus suggest that the preferred native state for PAXX is a dimer. While our 
analyses indicate that the conformation of PAXX is distinct from those of other XRCC4-
superfamily members, its overall structural properties most resemble those of XRCC4 (Fig. 1E 
and S2C). 
 
To gain insights into PAXX function, we expressed green-fluorescent protein (GFP), GFP-
tagged wild-type (WT) PAXX and GFP-tagged C-terminally truncated PAXX1-145 in human 
293FT cells, purified these and identified potential binding partners by mass spectrometry. This 
revealed that the only proteins that bound GFP-PAXXWT but not GFP-PAXX1-145 or GFP 
corresponded to Ku70 and Ku80. Immunoprecipitation and western blot analyses confirmed this 
interaction and established that endogenous PAXX and Ku interact (Fig. 2, A and B). Also, in 
reciprocal experiments Ku70 (GFP-tagged at its endogenous gene locus) interacted with PAXX 
(Fig. S3A). Given that GFP-PAXX1-145 did not interact with Ku and because the extreme C-
terminus of PAXX has been highly conserved through evolution (Fig. 2C), we speculated that 
PAXX C-terminal residues might mediate Ku binding. To test this, we synthesized a biotinylated 
peptide encompassing PAXX residues 177-204 and found that it specifically retrieved two major 
proteins that were identified by mass spectrometry to be Ku70 and Ku80 (Fig. 2D); this was 
confirmed by western blotting (Fig. S3B). Furthermore, mutating two of the most highly 
conserved residues in the PAXX C-terminus (V199 and F201) to alanine in GFP-PAXXWT or 
biotinylated PAXX177-204 abolished interaction with Ku (Fig. 2E and S3B). In line with these 
findings, addition of PAXX177-204 peptide to cell lysates inhibited the interaction of PAXX with 
Ku (Fig. S3C), and surface-plasmon-resonance (SPR) studies with purified proteins established 
that DNA-bound Ku and PAXXWT interacted directly, while PAXXV199A/F201A did not bind to 
Ku-DNA detectably (Fig. S3, D and E). Thus, PAXX binding to Ku-DNA is direct and is 
mediated by the PAXX C-terminus. 
 
In vivo, PAXX was predominantly nuclear (Fig. S4, A and B), and GFP-PAXX localized to 
DNA damage generated by laser micro-irradiation of live cells (Fig. 3A). To test if PAXX might 
be involved in DSB repair by NHEJ, we depleted human U2OS cells of PAXX using multiple 
small-interfering RNAs (siRNAs; Fig. S4C), then performed clonogenic survival assays after 
exposing the cells to IR. Cells in which PAXX was depleted were significantly more 
radiosensitive than control cells, displaying similar sensitivities to cells depleted of XRCC4 (Fig. 
3B and S4D). Furthermore, expression of PAXXWT but not PAXXV199A/F201A restored IR 
resistance in PAXX-depleted cells (Fig. 3B). As PAXXV199A/F201A is impaired for Ku binding, 
these data support a model in which the PAXX-Ku interaction is crucial for PAXX function in 
DNA repair. 
 
To verify and extend the above conclusions, we used CRISPR-Cas9 gene-editing (12) in non-
transformed human RPE-1 cells to generate PAXX-/- clones (Fig. S5). Like siRNA-treated U2OS 
cells, PAXX-/- cells were hypersensitive to IR and the radiomimetic drug phleomycin (Fig. 3C 
and Fig. S6B). Furthermore, by depleting XRCC4 or XLF in PAXX+/+ or PAXX-/- cells (Fig. 
S6C), we established that combined loss of PAXX and XRCC4, or PAXX and XLF, did not 
cause IR sensitivity greater than that of PAXX-/- cells or cells depleted of XRCC4 or XLF alone 
(Fig. 3C and Fig. S6D), implying that PAXX functions epistatically with XRCC4 and XLF to 
promote IR resistance via classical NHEJ. Given that NHEJ-deficient cells display defective 
resolution of IR-induced γH2AX foci, we compared the appearance and disappearance of these 
foci by immunofluorescence microscopy in PAXX+/+ and PAXX-/- cells. While PAXX loss did 
not impair γH2AX focus formation, we observed a significant defect in γH2AX focus resolution 
in multiple PAXX-/- clones (Fig. 3D). Furthermore, both PAXX-/- RPE-1 and PAXX-depleted 
U2OS cells were impaired in repairing DSBs as measured by neutral comet assays (Fig. 3E and 
Fig. S6E), and PAXX-depleted U2OS cells were also defective in random-plasmid integration, 
which occurs through NHEJ events (Fig. S6F) (13). As with other NHEJ factors such as XRCC4, 
PAXX loss did not impair checkpoint signaling (Fig. S7, A and B). 
 
Subsequent biochemical investigations established that, while not binding DNA detectably on its 
own, PAXX retarded the electrophoretic mobilities of DNA complexes containing two Ku 
molecules (Fig. 4A and Fig. S8A-C). Furthermore, such binding was abrogated in the presence 
of a large excess of PAXX177-204 peptide, or when the extreme PAXX C-terminal region was 
absent or contained alanine substitutions of V199 and F201 (Fig. 4A and S8D). We next tested 
whether PAXX affected DNA ligation by LIG4 in vitro in a manner dependent on its ability to 
bind Ku. Indeed, PAXXWT but not PAXXV199A/F201A markedly stimulated double-stranded DNA 
ligation in reactions containing the XRCC4/LIG4 complex, but only in the presence of Ku (Fig. 
4B). We speculated that PAXX might act as a scaffold to stabilize two Ku heterodimers at DNA 
ends and thus promote assembly and/or stability of the NHEJ machinery at DSB sites. To test 
this, we treated PAXX+/+ and PAXX-/- cells with phleomycin and examined the association of 
NHEJ proteins with chromatin by western blotting. This revealed that PAXX deficiency 
produced substantial defects in the ability of Ku, DNA-PKcs, XRCC4 and XLF to assemble on 
chromatin in response to DNA damage, without affecting the overall levels of these proteins 
(Fig. 4C and S8E). 
 
In conclusion, we have identified and characterized a novel XRCC4-superfamily member, 
PAXX. We have shown that PAXX binds Ku and promotes DSB repair at the biochemical and 
cellular levels and stabilizes NHEJ-protein assembly at DSB sites (Fig. 4D), thus establishing 
PAXX as a hitherto uncharacterized NHEJ factor. 
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Figure legends: 
Fig. 1. Crystal structure of PAXX. (A) Domain architecture of human PAXX and other XRCC4-
superfamily members. Sequence identities between human PAXX and XRCC4, XLF and SAS6 
are 10.9, 11.2 and 10.1% respectively. (B) Structure of a PAXX dimer with the two polypeptide 
chains shown in cyan and pink. The N- and C-termini of the structure are indicated as N-ter and 
C-ter respectively. (C) Residues mediating the PAXX dimerization interface, with β-sheet 
sandwich-like packing between protomers in adjacent asymmetric units. The packing of each 
strand from different protomers is shown in surface and stick representations. Black dotted lines 
are hydrogen bonds between side-chain pairs (S95 and S99, T97 and T97, S99 and S95) and 
between the side-chain of D108 of each protomer with the main chain of A104 of the adjacent 
protomer in the crystals. (D) ES-MS profile showing that PAXX1-204 is a dimer. Three charge 
states are observed for the dimer. The main charge state 13+ is labeled in the mass spectrum. (E) 
Comparison of XRCC4-superfamily members. The head domains of PAXX (cyan), XRCC4 
(silver), XLF (magenta) and SAS6 (lime) are superimposed.  
  
Fig. 2. The PAXX C-terminus interacts with Ku. (A) GFP-pulldowns showing that GFP-
PAXXWT but not GFP-PAXX1-145 transiently overexpressed in 293FT cells interacts with Ku. (B) 
Co-IP from HeLa nuclear extracts showing that endogenous PAXX and Ku interact. (C) 
Sequence alignment of the C-termini of PAXX orthologs. Conserved residues are indicated with 
reverse shading and similar residues are highlighted in grey. (D) Peptide pulldowns from HeLa 
nuclear extracts using control (H2AX) or PAXX177-204 peptides analysed by silver staining. “M” 
represents protein markers, and numbers represent molecular weights in kDa. (E) GFP-pulldown 
showing that PAXX residues V199 and F201 are required for Ku binding in the context of full-
length PAXX. 
  
Fig. 3. PAXX is required for DSB repair in human cells. (A) GFP-tagged PAXX accumulates at 
sites of laser micro-irradiation in U2OS cells. White arrowheads indicate the path of the laser 
used to induce DSBs. (B) Clonogenic survival assay showing that PAXX depletion in U2OS 
cells causes radiosensitivity and that this is rescued by exogenous expression of PAXXWT but not 
PAXXV199A/F201A. In this experiment and those below, error bars represent the standard error of 
the mean (SEM) from 3 independent experiments. (C) Clonogenic survival assay showing that 
PAXX-/- cells are radiosensitive and that PAXX loss is epistatic with XRCC4 depletion. (D) 
PAXX-/- cells display persistent γ-H2AX foci after IR. Cells with >5 foci were scored as positive, 
and were co-stained with Cyclin A to eliminate S and G2 cells from analysis. At least 100 cells 
were scored per condition. “cl.” indicates clone number. (E) PAXX is required for cellular DSB 
repair as measured by neutral comet assay. R/D ratios represent mean tail length of cells treated 
with 40 µg/ml phleomycin for 2 hours and allowed to recover (R) for 2 hours over mean tail 
length of cells damaged (D) for 2 hours without recovery. 
  
Fig. 4. PAXX promotes NHEJ in vitro and stabilizes NHEJ proteins on damaged chromatin. (A) 
EMSA of Ku and PAXX derivatives with 50-bp 6-FAM(6-carboxyfluorescein)-labelled DNA. 
200 nM PAXX and 20 nM Ku were added where indicated. (B) Stimulation of DNA-end ligation 
by PAXX. 50 ng of pcDNA3.1(-) digested by EcoRV was incubated with XRCC4/LIG4 (25 
nM), Ku (25 nM), PAXX (250 nM) and PAXXV199A/F201A (250 nM) as indicated (left). Ligation 
efficiency (right) was calculated as a percentage of ligated plasmid from four independent 
assays. (C) Chromatin fractionation of PAXX+/+ and PAXX-/- cells treated with phleomycin as 
indicated. Note that DNA-damage-dependent chromatin recruitment of proteins such as RPA, 
that function in DNA repair pathways other than NHEJ, were unaffected by PAXX loss. (D) 
Model of PAXX in NHEJ. Two Ku-bound DNA-ends are bound by a PAXX dimer via its C-
termini, which stabilizes the NHEJ machinery to promote DNA-end ligation. 
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Materials and Methods 
 
Construct design and purification 
The synthesised cDNA of human PAXX (C9orf142) optimised for Escherichia coli 
expression (Life Technologies) was cloned into the pHAT4 vector (14), with a hexa-
histidine tag followed by a TEV cleavage site used for PAXX1-145, PAXX1-166 and 
PAXX1-204, or into pGAT3 vector (a gift from Dr. M. Hyvönen), with a hexa-histidine tag 
followed by a GST tag and a TEV cleavage site used for PAXX1-190 and PAXX1-204. The 
pGAT3 vector carrying the PAXX1-204 open-reading frame (ORF) was used for site-
directed mutagenesis to produce PAXXV199A, PAXXF201A and PAXXV199A/F201A. The 
coding regions of PAXX1-204 and PAXXV199A/F201A were amplified from the vectors by 
PCR and cloned into the pcDNA3.1(-) vector (a gift from Dr. V. Bolanos-Garcia) 
together with GFP or FLAG tags using In-Fusion (Clontech). Vectors were sequenced by 
the DNA-sequencing facility, Department of Biochemistry, University of Cambridge. 
Bacterial expression vectors were transformed into BL21(DE3) (New England Biolabs). 
PAXX derivatives with 6xHis tags only were purified by Ni-affinity column and gel 
filtration. PAXX1-166 and PAXX1-204 were further purified by cation-exchange 
chromatography. Derivatives with GST tags were purified by GST-affinity column, Ni-
affinity column and gel filtration chromatography. All tags were cleaved by TEV after 
the first chromatography step. Proteins were stored in final buffer 20 mM Tris-HCl pH 
7.5, 100 mM NaCl, 2 mM DTT) at -80 ºC. Bands from the final SDS-PAGE gels were 
analyzed using mass spectroscopy by Dr. L. Packman (PNAC facility, Department of 
Biochemistry, University of Cambridge) or Dr. B. Kessler (Target Discovery Institute, 
University of Oxford). Purification of XRCC4/LIG4 was carried out as described 
previously (15). The co-expression vector of Ku was a generous gift from Dr. L. 
Hanakahi (Johns Hopkins University), and protein expression and purification were 
carried out as described (16). However, the lysis step was modified and an additional gel 
filtration step was added at the end. For lysis, wet cell pellet was suspended in 5 ml/g of 
cells in 50 mM sodium phosphate buffer pH 7.5, 150 mM NaCl, 5% (v/v) glycerol, 2 mM 
2-mercaptoethanol, 10 µg/ml of RNase, 20 µg/ml of DNase supplied with cOmplete, 
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EDTA-free protease inhibitor cocktail (Roche). Lysate was incubated at 4 ºC at 30 min 
after the re-suspended cells were sonicated. Lysate was diluted 5-fold to make the final 
lysis buffer (50 mM sodium phosphate buffer pH 8.0, 1 M NaCl, 10% (v/v) glycerol, 400 
mM ammonium acetate, 2 mM 2-mercaptoethanol, 10 mM imidazole, protease inhibitor 
cocktail). Debris was removed by centrifuging at 25,000 x g for 30 min, 4 ºC. For gel 
filtration, Ku eluted from 5 ml HiTrap heparin HP column (GE Healthcare) was 
concentrated and loaded onto Superdex200 16/60 or 10/300 (GE Healthcare), which was 
equilibrated with 20 mM HEPES pH 7.5, 500 mM NaCl, 5% (v/v) glycerol, 2 mM DTT, 
depending on sample volumes. A single peak containing Ku heterodimer was collected 
and diluted 5-fold with 20 mM HEPES pH 7.5, 100 mM NaCl, 5% (v/v) glycerol, 2 mM 
DTT. The sample was concentrated, analyzed by SDS-PAGE (Fig. S8A), and stored at -
80 ºC after being snap-frozen in liquid nitrogen. 
  
Crystallisation and structure determination 
10 mg/ml of a) PAXX1-145, b) PAXX1-166 and c) PAXX1-204 were crystallized at 18 ºC in 
the following conditions respectively: a) 1.4-1.6 M ammonium sulphate, 100 mM Tris-
HCl pH 7.6-8.4; b) 1.5 M ammonium sulphate, 12-15% (v/v) glycerol, 100 mM Tris-HCl 
pH 8.2-8.8; and c) 1 M sodium malonate pH 6.0, 1% (v/v) 1,4-dioxane. The derivative 
crystals of PAXX1-145 were prepared by soaking crystals in the crystallization solution 
with 1 mM KAu(CN)2 for 120 min and by back-soaking in the crystallization solution for 
120 min. Native and derivative crystals were then cryo-protected in crystallization 
solutions containing 30% (v/v) glycerol before flash freezing in liquid nitrogen. X-ray 
diffraction data were collected at I03 in the Diamond Light Source (Oxford, UK). 
Collected data were processed by XDS (17) and scaled using Aimless (18) (Table S3). 
The phenix.autosol module of PHENIX suite (19) was used to calculate experimental 
phases for structure factors by SAD method (FOM: 0.311 and overall score: 49.85). The 
initial model was built using the phenix.autobuilt module and used to solve the structure 
of PAXX1-166 by molecular replacement using the phenix.phaser module because the 
diffraction data quality of PAXX1-166 was better than that of PAXX1-145 (Table S3). The 
placed model was manually and computationally refined using Coot (20) and the 
phenix.refine module against the native data set of PAXX1-166 until the improvement of 
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the model converged (Table S3). The structural model was used to calculate phases of 
structure factors of PAXX1-204 datasets by molecular replacement using the phenix.phaser 
module. Model building and refinement were performed in a similar manner to those of 
PAXX1-166 (Table S3). The constructs crystallized in the same space group with similar 
cell parameters (Table S3) and with very similar crystal packing. Due to their being 
disordered, PAXX residues after 145 were not observed in the crystal structures. 
 
Electrospray mass spectroscopy 
Prior to MS analysis, samples were buffer exchanged into 200 mM ammonium acetate 
(pH 7.8) using micro biospin 6 columns (BioRad). Mass spectra were obtained on a Q-
ToF mass spectrometer previously modified for high-mass transmission (21). The 
samples were introduced using a method to preserve noncovalent interactions (22). The 
mass spectra were obtained under following instrumental conditions: sample cone 100 V, 
capillary voltage 1500 V, extractor cone 10 V, collision cell energy 10 V, source backing 
pressure 4.5 x 10-3 mbar. Measured molecular weights of PAXX1-145 and PAXX1-204 are 
shown in Table S4. 
 
Small angle X-ray scattering (SAXS) 
SAXS data of 2-10 mg/ml of PAXX1-145 were collected at I22 of Diamond Light Source. 
Data collection was carried out at 5 ºC using a BIOSAXS robot. Buffer (20 mM Tris-HCl 
pH 7.5, 100 mM NaCl, 2 mM DTT) and each sample was exposed to the beam 
alternately in 20 frames of 1 s. Scattering intensities were measured using the Pilatus 2M 
detector at 3.2 m distance. Data reduction was carried out using DAWN. ScÅtter 
(http://www.bioisis.net/) was used to merge 2 and 10 mg/ml scattering data of the 
construct. The samples were shown to be monodisperse by checking Guinier plots in the 
Guinier region generated using ScÅtter (Figure S9A). The distance distribution function 
(Figure S9B) and Rg (Table S4) of the construct was calculated from the merged data 
using GNOM (23). The complete model of PAXX1-145, in which missing side chains and 
loops were added, was created using Modeller (24), and scattering intensities of the 
model were simulated and compared with measured intensities using CRYSOL (25). Ten 
individual models of PAXX1-145 created using DAMMIN (26) with the no-symmetry 
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operation were superimposed and averaged using SUPCOMB (27) and DAMAVER (28) 
(normalized spatial discrepancy: 0.566). The UCSF Chimera package (29) was used to 
visualize the averaged DAMMIN model and to fit crystallographic models into the 
envelopes. 
  
Cells, siRNAs and transfections 
293FT, U2OS and HeLa cells were cultured in Dulbecco’s modified Eagle (DME) 
medium (Sigma-Aldrich) supplemented with 10% fetal bovine serum (BioSera), 2 mM L-
glutamine, 100 units/ml penicillin and 100 µg/ml streptomycin (Sigma-Aldrich). RPE-1 
cells were cultured in DME/F12 1:1 medium supplemented as above and additionally 
buffered with 0.2% Na(CO3)2. Stable U2OS and RPE-1 lines were established by 
selection in medium containing 500 µg/ml G418 (Life Technologies). RPE-1 cells 
expressing GFP or GFP-Ku70 from the endogenous locus were generated previously 
(30). Plasmids were transfected into cells using Lipofectamine 2000 (Life Technologies) 
or by electroporation using the Neon system according to the manufacturer’s instructions 
(Life Technologies). siRNAs were transfected using Lipofectamine RNAiMAX (Life 
Technologies) according to the manufacturer’s instructions, with the following sense 
sequences: siCtrl (targeting firefly luciferase), 5'-CGUACGCGGAAUACUUCGA-3'; 
siPAXX-1, 5'-CAGGAGAGUCGCUCAUCAA-3'; siPAXX-2, 5'-
UAACACGGCUCCUCAAAUU-3'; siXRCC4, 5'-AUAUGUUGGUGAACUGAGA-3', 
siXLF 5'-CGCUGAUUCGAGAUCGAUUGA-3'. 
  
Antibodies, SDS-PAGE and western blotting 
Whole cell extracts were obtained by washing cells in phosphate-buffered saline (PBS) 
before lysis in SDS loading buffer (2% SDS, 10% (v/v) glycerol, 25 mM TCEP and 62.5 
mM Tris-HCl, pH 6.8). Extracts were heated at 95 °C for 5 min, followed by shearing 
with 10 strokes through a 25G needle. Protein concentrations were determined by 
Bradford assay (Bio-Rad) or NanoDrop (Thermo Scientific). SDS-PAGE and western 
blotting were performed using the Novex NuPAGE SDS-PAGE gel system (Life 
Technologies) or the SE400 and TE42 systems from Hoefer. The following antibodies 
were used at the indicated dilutions: CHK1 (sc8408, Santa Cruz Biotechnology, 1/1000), 
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CHK1-pS345 (2348, Cell Signaling Technology, 1/10,000), CHK2-pT68 (2661, Cell 
Signaling Technology, 1/500), DNA-PKcs (MS-369-P1, Thermo Scientific, 1/200), GFP 
(11814460001, Roche, 1/5000), γH2AX (05-636, Millipore, 1/1000), H3 (ab1791, 
Abcam, 1/50,000), H3-pS10 (ab14955, Abcam, 1/5000), Ku70 (ab3114, Abcam, 1/1000), 
Ku80 (MS-285-P1, Thermo Scientific, 1/2000), p21 (sc397, Santa Cruz Biotechnology, 
1/1000), p53 (554293, BD Biosciences, 1/6000), PAXX (ab126353, Abcam, 1/500), 
RPA1, (A300-241A, Bethyl Laboratories, 1/1000), TopBP1 (A300-111A, Bethyl 
Laboratories, 1/5000), XLF (ab33499, Abcam, 1/650) and XRCC4 (ab145, Abcam, 
1/3000). 
  
Immunofluorescence of fixed cells 
For analyses of γH2AX foci, cells grown on glass coverslips were treated with 2 Gy of IR 
delivered by a CellRad system (Faxitron). Cells were fixed in 2% paraformaldehyde for 
15 min at room temperature, permeabilized with PBS/0.2% Triton X-100 for 5 min and 
blocked with blocking buffer (5% BSA (w/v) and 0.1% Tween-20 in PBS). Cells were 
incubated with the following primary antibodies: γH2AX (05-636, Millipore, 1/1000) and 
Cyclin A (sc-751, Santa Cruz Biotechnology, 1/200), followed by secondary antibodies 
and 1 µg/ml DAPI in blocking buffer. Images were acquired using an Olympus FluoView 
1000 confocal microscope. For analyses of centrosomal localization, HeLa cells grown 
on glass coverslips were transfected with pcDNA3.1(-) encoding Flag-PAXX and 24 
hours later fixed with methanol at 4 ºC for 1 min. Cells were blocked with blocking 
buffer and incubated with the following primary antibodies: Flag (F7425, Sigma-Aldrich, 
1/250) and γ-tubulin (T5326, Sigma-Aldrich, 1/500) followed by secondary antibodies 
and 0.5 µg/ml DAPI in blocking buffer. Images were acquired using an Applied Precision 
DeltaVision core microscope equipped with a Mercury 100 W lamp and CoolSnap HQ 
camera (Photometrics). 
  
Peptide pulldown assays 
Biotinylated PAXX177-204 and PAXX177-V199A/F201A-204 peptides were synthesised 
(Biomatik) and 250 µg was incubated with 400 µg of Dynabeads M-280 streptavidin 
(Life Technologies) equilibrated with 150 µl of TBS supplied with 0.1% (v/v) Igepal CA-
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630 at 4 ºC for 1 hour. A peptide corresponding to the C-terminus of H2AX was used as a 
control (31). After washing with buffer six times, beads were suspended in 100 µl of 
buffer P1 (50 mM Tris-HCl pH 8.0, 300 mM NaCl, 10% (v/v) glycerol, 5 mM NaF, 1 
mM EDTA, 0.2% (v/v) Igepal CA-630, 1x cOmplete Protease Inhibitor Cocktail, EDTA 
free (Roche)). Beads were added to 500 µl of HeLa nuclear extract (Cilbiotech), which 
was diluted with the same volume of P1 and centrifuged at 17,200 x g, 4 ºC for 1 min. 
The mixture was incubated at 4 ºC for 3 hours and washed with P1 six times before 10 µl 
of 3x SDS-PAGE sample loading buffer was added. Pulldown samples were analysed by 
SDS-PAGE and the gel was visualized with silver stain (Pierce). Bands were analysed by 
GELC-MS/MS at the Cambridge Centre for Proteomics. 
  
Immunoprecipitations 
For preparation of lysates for immunoprecipitations (IPs), cells were washed twice in 
PBS, and lysed in IP buffer (100 mM NaCl, 0.2% (v/v) Igepal CA-630, 1 mM MgCl2, 
10% (v/v) glycerol, 5 mM NaF, 50 mM Tris-HCl, pH 7.5), supplemented with cOmplete 
EDTA-free protease inhibitor cocktail (Roche) and 25 U/ml Benzonase (Novagen). After 
nuclease digestion, NaCl and EDTA concentrations were adjusted to 300 mM and 2 mM, 
respectively, and lysates were cleared by centrifugation. Where appropriate, antibodies 
were added to a final concentration of 1 µg/mg lysate and incubated for 2 hours at 4 °C. 
Lysates were then incubated with 10 µl of GFP-Trap agarose beads (ChromoTek) or 20 
µl of protein G Sepharose (GE Healthcare) for 2 hours with end-to-end mixing at 4 °C. 
Beads were washed five times in IP buffer before resuspension in 2x SDS loading buffer. 
5% input lysate was loaded alongside unless otherwise stated. 
  
Surface plasmon resonance 
SPR experiments were performed using a Biacore T100 (GE Healthcare). 250 RU of 107 
bp biotinylated DNA was immobilized using a wizard on channels 1 and 2 of an SA chip 
by following a recommended instruction (GE Healthcare). The DNA fragment was 
created using human LIG4 gene as template by PCR reaction using a forward primer (5'-
ATATATCCATGGCTGCCTCACAAACTTCACAA-3') and reverse primer (5'-biotin-
TGCACGTCCTTTACTTTTCTGTAT-3'). 750 RU of Ku was then manually 
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immobilized on the channel 2 at 5 µl/min in 20 mM Tris-HCl pH 7.5, 150 mM NaCl, 2 
mM DTT, 0.005% (v/v) Tween-20. 5, 10, 20, 40 and 80 nM of PAXX1-204 or 
PAXXV199A/F201A was flowed through channels 1 and 2 at 30 µl/min, 25 ºC for 60 s 
followed by washing with the buffer for 600 s using a kinetics wizard. A peptide-
competition analysis was carried out in a similar way using 20 nM PAXX1-204 with and 
without 20 nM-2 µM of PAXX177-204 or 2 µM PAXX177-V199A/F201A-204 (Biomatik). The 
dissociation constant of Ku and PAXX was calculated by BIAevaluation (GE Healthcare) 
assuming the Ku heterodimer and PAXX homodimer interact in a one-to one ratio (Fig. 
S9C). 
  
Generation of PAXX-/- cells by CRISPR-Cas9 
The PAXX knock-out strategy is displayed in Fig. S5A. Guide RNAs (gRNAs) targeting 
exon 4 of the C9orf142 gene were selected using the Optimized CRISPR Design tool 
(http://crispr.mit.edu; (32)), with the following sequences: 
AGCCACAGCTTGCTGCTCAC (gRNA1) and AGCATCCCTGACGCTTTCAG 
(gRNA2). gRNA sequences were purchased as DNA oligonucleotides (Sigma-Aldrich) 
and cloned into pU6 gRNA cloning vector (a gift from Dr. W. Skarnes). The pMA-
C9orf142 targeting vector (Fig. S5B) was constructed using the GeneArt plasmid 
construction service (Life Technologies). RPE-1 cells were transfected with pMA-
C9orf142, human codon-optimized Cas9-D10A nickase (plasmid 41816, Addgene; (33)) 
and gRNA plasmids, and left to recover for 3 days before addition of selective medium 
containing 750 µg/ml G418. After 10 days, cells were selected based on GFP status using 
a MoFlo cell sorter (Beckman Coulter) and colonies were allowed to form from single 
cells. PAXX expression was analyzed by western blotting for 26 clones, of which 25 
were found to have lost all detectable PAXX protein (data not shown). Genomic DNA 
(gDNA) from 2 cell clones was further analyzed by two rounds of PCR, firstly to confirm 
that the targeting cassette had integrated in the C9orf142 locus and secondly, to decipher 
the fate of the second, non-targeted allele. gDNA was extracted and purified using a 
QIAamp DNA Mini Kit (Qiagen) according to the manufacturer’s instructions. To 
confirm targeted integration of the cassette to replace the endogenous C9orf142 gene, the 
following primers were used: TTCTTGCCGAGCCTTGAACA (forward, primer 1) and 
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GGACGACGGCAACTACAAGA (reverse, primer 2). To sequence the second allele, the 
following primers were used to amplify the region of the C9orf142 gene containing the 
Cas9 cut site: GCGGCTTCAACCTCTAGTGA (forward, primer 3) and 
TGTGGGAGGGTACCTCTTGA (reverse, primer 4). Primer 4 was used to sequence the 
PCR product to characterize the disruption event at the second allele. Results from these 
analyses are shown in Fig. S5C. 
  
Clonogenic survival assays 
Where appropriate, cells were transfected with siRNAs and left to grow for 3 days. Cells 
were treated with ionized radiation delivered by a CellRad machine (Faxitron) or 
phleomycin (Melford Laboratories) for 2 hours, followed by 3 washes in PBS. Cells were 
left to form colonies for 7–14 days, and colonies were stained with 0.1% (w/v) crystal 
violet in 20% (v/v) ethanol for counting. Results were normalized to plating efficiencies 
of untreated cells. 
  
Neutral comet assays 
Where indicated, cells were transfected with siRNAs and left to grow for 3 days. Cells 
were mock-treated or damaged with 40 µg/ml phleomycin for 2 hours. For the recovery 
samples, cells were washed twice with PBS and cultured for a further 2 hours after 
phleomycin treatment. Cells were washed twice in MgCl2/CaCl2-free (-/-) PBS (Life 
Technologies) and harvested by scraping. Cells were resuspended at an approximate 
concentration of 5 x 106/ml in (-/-) PBS, and 10 µl of resuspended cells were mixed with 
90 µl of LMAgarose (Trevigen) at 37 °C, before being spotted onto GelBond Film 
(Lonza), covered with a 22-mm cover slide (VWR International) and left at 4 °C for 10 
min. Cover slides were removed, and cells were incubated in lysis solution (Trevigen) at 
4 °C for 1 hour. Cells were washed in 90 mM Tris borate, pH 8.3 and 2 mM EDTA 
(TBE) and subjected to electrophoresis at 35 V for 7 min in TBE. Samples were fixed in 
70% ethanol for 5 min and left to dry overnight. DNA was stained with SYBR Green I 
(Life Technologies) in 10 mM Tris-HCl (pH 7.5) and 1 mM EDTA for 10 min, and left to 
dry overnight. Images were taken with an IX71 fluorescent microscope and Cell^F 
software (Olympus). Tail moments were measured using CometScore software (TriTek). 
 
 
10 
 
Mean tail moments were measured and calculated from at least 50 cells per condition. 
Efficiency of DSB repair was determined as the mean tail moment ratio between DNA 
from recovered and damaged cells. 
  
Random plasmid integration NHEJ assays 
Two days after siRNA transfection, cells were transfected with BamHI/XhoI-linearized 
pEGFP-C1, before being plated at high and low densities the next day. Cells at high 
densities were treated with 1 mg/ml G418 1 day after plating, and colonies were allowed 
to grow for 10-14 days. Cells were stained with 0.1% (w/v) crystal violet in 20% ethanol 
for counting. Random plasmid integration events were normalized for plating efficiency 
and normalized to siCtrl samples to obtain final values for NHEJ efficiency. 
  
Laser micro-irradiation and live cell imaging 
Assays were performed as described previously (34). 
  
Electrophoretic mobility shift assays (EMSAs) 
50-bp dsDNA labelled with 6-FAM(6-carboxyfluorescein) was created by annealing a 
forward primer (5'-6FAM-
TAAATGCCAATGCTGCTGATACGTACTCGGACTGATTCGGAACTGTAACG -3') 
and reverse primer (5'-
CGTTACAGTTCCGAATCAGTCCGAGTACGTATCAGCAGCATTGGCATTTA-3'). 
For the assays using the NHEJ ligase complex, 10 nM of 50-bp DNA was incubated with 
proteins as indicated in the main text in 20 mM Tris-HCl pH 7.5, 50 mM KCl, 5% (v/v) 
glycerol, 100 µM DTT, 10 µg/ml BSA. Samples were incubated at room temperature for 
30 min and applied onto a 5% polyacrylamide gel in 0.5x TBE buffer for electrophoresis. 
DNA was visualized by Typhoon 9000 (GE Healthcare). The DNA-binding assay using 
pFastBacHTB digested with HindIII and BamHI was carried in a similar manner. The 
incubated samples were applied to a 0.8% (w/v) agarose gel in 0.5x TBE buffer for 
electrophoresis. DNA was stained with SYBR Gold (Life Technologies) and visualized 
using a UV imager. 
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DNA ligation assays 
pcDNA3.1(-) was digested with EcoRV (New England BioLabs) and purified using 
NucleoSpin Gel and PCR Clean-up (Clontech). 50 ng of the digested plasmid was mixed 
with the indicated quantities of proteins in 20 µl of reaction buffer containing 25 mM 
Tris-HCl pH 7.5, 150 mM KCl, 1 mM MgCl2, 1 mM DTT, 10 µM ATP, 10% (w/v) 
PEG10,000, 10 µg/ml BSA. Mixtures were incubated at 37 ºC for 5 min before initiating 
ligation by XRCC4/LIG4 at 37 ºC for 30 min. The mixtures were incubated at 50 ºC for 
another 30 min after adding 2 µl of a reaction-stop solution (100 mM EDTA, 0.1% (w/v) 
SDS) and 0.2 µl of 20 mg/ml Proteinase K. Reaction mixtures were applied onto 0.8% 
agarose gel in TBE buffer for electrophoresis. The gel was stained with SYBR Gold, 
visualized using a UV imager and quantified using GeneTools (Synegene). 
  
Chromatin fractionation 
Cells were mock-treated or treated for 1 hour with 300 µM phleomycin to induce large 
numbers of DSBs, before being harvested either at this point or after an additional 1-hour 
recovery period in phleomycin-free medium after three PBS washes. Cells were washed 
twice in ice-cold PBS, and pre-extracted twice for 3 min at 4 °C in CSK buffer (100 mM 
NaCl, 300 mM sucrose, 3 mM MgCl2, 0.7% Triton X-100, 10 mM PIPES, pH 7.0), 
supplemented with 0.3 mg/ml RNase A (Sigma-Aldrich). After pre-extraction, cells were 
washed 3 times in ice-cold PBS and harvested in SDS loading buffer for analysis by 
SDS-PAGE and western blotting. 
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Archaea1    ( 501 )    vVIeVtYq-eIqksp----ky---------rSgFaLrfPrfvAlrdDkgp 
Archaea2    ( 527 )    yVAeIiGs-eItisp----lHTCcqdvvekdAGLsIrfprFIrwrddksp 
Archaea3    ( 498 )    yVFEVaYq-eIqksp----ky---------eSgyaLrfprFvrlRddKdv 
hLigI       ( 840 )    aVWeVkCa-dLslsp----iyPAArglvdsdkGIsLrfprFirvredkqp 
hLigIII     ( 693 )    aVWeItGa-efskse----aht--------AdgIsirfprCtrirddkdw 
Archaea1               VVIEVTYQ-EIQKSP----KY---------RSGFALRFPRFVALRDDKGP 
Archaea2               YVAEIIGS-EITISP----LHTCCQDVVEKDAGLSIRFPRFIRWRDDKSP 
Archaea3               YVFEVAYQ-EIQKSP----KY---------ESGYALRFPRFVRLRDDKDV 
hLigI                  AVWEVKCA-DLSLSP----IYPAARGLVDSDKGISLRFPRFIRVREDKQP 
hLigIII                AVWEITGA-EFSKSE----AHT--------ADGISIRFPRCTRIRDDKDW 
Human       ( 555 )    VIVQIKAA-EIVPSD----MY---------KTGCTLRFPRIEKIRDDKEW 
Orangutan   ( 555 )    VIVQIKAA-EIVPSD----MY---------KTGCTLRFPRIEKIRDDKEW 
Mouse       ( 555 )    VIVQIKAA-EIVPSD----MY---------KTGSTLRFPRIEKIRDDKEW 
Chicken     ( 560 )    VIVQIKAA-EIVNSD----MY---------KTDCTLRFPRIEKIREDKEW 
Frog        ( 560 )    VILQIKAA-EIVSSD----MY---------KTGCTLRFPRIEKIREDKEW 
Fly         ( 566 )    VILQVKAA-DLAPNG----AF---------FTRKSLHFPRTEMKRDDKTW 
Fungus      ( 627 )    VVICVKAA-SVSASD----QF---------RLGLTLRFPRFKRLRMDKDW 
Fungi       ( 624 )    VVLCVKAA-SVAVSD----QF---------RIGLTLRFPRFKKLRMDKDW 
Plant       ( 551 )    IILSITSDIRTIRSE----VF---------VAPYSLRFPRIDKVRYDKPW 
Yeast1      ( 590 )    IVLEIKSR-SLDNTETNMQKY---------ATNCTLYGGYCKRIRYDKEW 
Yeast2      ( 584 )    LVLQIKAA-EVVVSN----RF---------KTNYTLRFPRLEKVRLDRSW 
                                                             ===mVI==== 
Archaea1    ( 537 )    edADtieRIaqLyelqekmkgkves                          
Archaea2    ( 572 )    edAttTdeIlemynkqpkk                                
Archaea3    ( 534 )    deAdtierVenLyklqf                                  
hLigI       ( 885 )    eqAttSaqVAclyrkqs                                  
hLigIII     ( 730 )    ksAtnlpqlkelyqlsk                                  
Archaea1               EDADTIERIAQLYELQEKMKGKVES------------------------- 
Archaea2               EDATTTDEILEMYNKQPKK------------------------------- 
Archaea3               DEADTIERVENLYKLQF--------------------------------- 
hLigI                  EQATTSAQVACLYRKQS--------------------------------- 
hLigIII                KSATNLPQLKELYQLSK--------------------------------- 
Human       ( 591 )    HECMTLDDLEQLRGK--ASGKLASKHLYIGGDDEPQEKKRKAAPKMKKVI 
Orangutan   ( 591 )    HECMTLDDLEQLRGK--ASGKLASKHFYVGGDDEPQEKKRKAAPKMKKVI 
Mouse       ( 591 )    HECMTLGDLEQLRGK--ASGKLATKHLHVGDDDEPREKRRKPISKTKKAI 
Chicken     ( 596 )    YECMTLDMLEHLRSR--AEGKLASKHLYIDEYDEPQEKKRRTVPKVKKVI 
Frog        ( 596 )    HECMTLDDLEQFRDK--ASGKLASKHLDV--DDEPHEKKRKTAPKLKKVI 
Fly         ( 602 )    SECMTLKEFNDLCGGPLAIKKLNKRQLRL-EDVTTKRKQMRMTPSERSRL 
Fungus      ( 663 )    KSALSVQEFLDLKSN--VEQEHREKELNV-----DNSRRKRVKRTAKKPL 
Fungi       ( 660 )    KSALSVQEFLDLKAN--AERERKEKEFNV-----DNSRKKRAKRDNKKPL 
Plant       ( 588 )    HECLDVQAFVELVNS--SNGTTQKQKESESTQDNPKVNKSSKRGEKKNVS 
Yeast1      ( 630 )    TDCYTLNDLYESRT--------------VKSNPSYQAERSQLGLIRKKRK 
Yeast2      ( 620 )    KDALTINEFFTLKNA-----------VEKQDNVSFHVNKKRKVSQKREKQ 
                                                                       *  
Archaea1                                                                  
Archaea2                                                                  
Archaea3                                                                  
hLigI                                               The JOY format                              
hLigIII                                     ================================  
Archaea1               ---------------      alpha helix         : red 
Archaea2               ---------------      beta strand         : blue 
Archaea3               ---------------      310 helix            : maroon 
hLigI                  ---------------      solvent accessible  : lower case 
hLigIII                ---------------      solvent inaccessible: UPPER CASE 
Human       ( 639 )    GIIEHLKAPNLTNVN      hydrogen bond to  
Orangutan   ( 639 )    GIIEHLKAPNLTNVN      main-chain amide    : bold  
Mouse       ( 639 )    RIIEHLKAPNLSNVN      hydrogen bond to 
Chicken     ( 644 )    GIAEQFKAPDLSNVN      main-chain carbonyl : underline 
Frog        ( 642 )    GIVSHLKAPDLSNVH      disulfide bond      : cedilla 
Fly         ( 651 )    GLAVYEKRYDASTSA      positive phi torsion 
Fungus      ( 706 )    TVAGYDMDEDVKYAG      angle               : italic  
Fungi       ( 703 )    AIVGYSAEAEAQYTG      ================================ 
Plant       ( 636 )    LVPSQFIQTDVSDIK 
Yeast1      ( 666 )    RVLISDSFHQNRKQL 
Yeast2      ( 659 )    KKFLYDEPTFKKEAS 
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Figure S1
Capsaspora owczarzaki (unicellular)
Salpingoeca rosetta (unicellular)
Amphimedon queenslandica (sponge)
Danio rerio (zebrafish)
Xenopus tropicalis (frog)
Anolis carolinensis (lizard)
Mus musculus (mouse)
Homo sapiens (human)
Capitella teleta (polychaete worm)
Branchiostoma floridae (lancelet) 
Strongylocentrotus purpuratus (sea urchin)
Nematostella vectensis (sea anemone)
Gallus gallus (chicken)
fVCyCeGEesgegdrgg----FnLYVT Aa-e-- LWSTcftpdslaaLKarf--glsaaed-Itp FraACeq
wektLes-------gFvITLTdGh-s-- AWtgtvseseIsqeAddm--ame-----kgkYVgELrkA
KVfItkq----------GYALLVSdlq-q-- VWheqVdtsvVsqrAkel--Nkrltap-paaFLchLdnl
svIrVSIelqlpk-------dLvVrLTddt-dlyfLynliIseedFqslkvqq--gLlidftsFpqkFidlLeq
akqnhnlr-iLrIhIsSds-dlffLHtLeVseedFqslkndq--gilvdfasFpgkIislLek
net-sgek-eLkFeIsrsd-dfeFlFSetLnnekYqilardh--dLtvdFdaFPkvIiqhLLc
FVCYCEGEESGEGDRGG----FNLYVTDAA-E---LWSTCFTPDSLAALKARF--GLSAAED-ITPRFRAACEQ
LVCYCERDSGGDGDRDD----FNLYVTDAA-E---LWSTCFSPDSLARLKARF--GLSGAED-IHSRFRAACQQ
YLCYC-RPAPGPGSA------VTVYVTDAL-E---VWAGRLGGD--------------QPED-GVAELRAALGR
CLLFLE-------GKPR----SRILVTDAH-D---FWSLGAVASEAKEDSLKG--GSGSSD---ISRLREALAL
YLCHGR---GGDSSASP----LSVQVTDGV-E---VWGADVTEETLEEWSNSPPSVQNGAE-----KLRETFRR
YVFFTQK-----LPAGV----INIGFTNGE-D---VWKTHLSEEILSQLFKKF--SLKSTED-YTFKIKCACKT
-------MS YLCFTS------CDKDT----WIIHVTDGT-D---VWRLAMDYLQLESHRDLA--EVTTYEA-YFLRFRNAFRV
MAASVERAS YLVWTR----LSIDAGT----WIIVASDGV-D---VWRLELDKEQLISYRQLA--AADTFET-YFAQFRSDFQC
-------MS FVCFTR------CTAAA----WSISVTDGV-D---VWIWQAGQTELDAHRDVA--ELSSFEA-YFSRFRTAFLA
-------MS FLCYTR------MEKDS----FNISSTNGI-D---LWRAELSKEDIEGHSPDG--NVSNV----LIKIREAFKQ
YICYCT------VENEQ----WIVRLTDGT-S---VWK---SSDSLI----------NDLKI-TMKELRDYLQD
HICHVY---LHGARRPT----WTMSVTDGLRN---TWAHHFDVASLNQHRTAC--RIDSWRV-YFETIRKAFVA
--------M YILYSKLTDGRSEHAVDDGASWTLCMTDGF-Q-- VWTVDMTLADAQEHRDLF--QVS-FER-YFQHIRT MLT
qa-------------VaLtlqed-------rAsLtLsGgp-----------saL-aFdLskvp-gpeaaprlralTlgLAkrVwsLerrlaaaeet------------------------
Llsadv---------ytfnFskesa-----yFfFeknlkd---------vsfrLgsfnLekvenpaevIreLIayAldtiaenqaknehlqkenerLlrdwndvqgrfekavsakealet
lrpllkdaahpseAtFscdcvad-------aLiLrVrSel-------sglpFyW-nFhCmlAs--pslvSqHLIrPLMGMSLALqcQvreLatlLhmKdlEiqdYqesgatlirdrlkte
Ciceqdkenp----rflLqLsssssafdhspSnLnIvetn------adkhlthL-sLkLlpGs--dtdIkkyLascLssvkeekqqlqqklrktee------------------------
Cilaqpgdsp----rfqAvLtIrgg-----eSvFkIVein------dekqlphI-tLaFrpGn--dsvVkqfLafrLsevkgtçhdlsddLsrtrddrdsmvaqlaqÇrqqLaqlreqyd
                       knivkgk--------pTeInIiLdaekn--fCsFeLfskt------pISkgkIF-sIkLhavt---------------------------------------------------------
QA-------------VALTLQED-------RASLTLSGGP-----------SAL-AFDLSKVP-GPEAAPRLRALTLGLAKRVWSLERRLAAAEET-----------------AVSPRKS
QA-------------VTVSLQED-------RALITLSGDT-----------PAL-AFDLSKVP-SPEAAPRLQALTLSLAEHVCNLERRLAAAEET-----------------ITSPKKN
GT-------------VSLGLRDG-------AATLRLRE-------------GHE-ALLLPRLP-AAEARPQLQALLFAMAARVRDLEERLEVLGTL-----------------SYSPEKN
GR------------SPSVTLGDP-------TATLRLP---------------GV-TLDLEKAP-PAEARKELQGLMFALAEKVQALEQRLQEVL-------------------AASPVSS
SS-------------PLLDIQGS-------SASLLFPKDS-----------ANV-TLCLFKLP-VSEARGHVRSLVFDLSDRVWELEKLQKEGSAPT----------------SASPVKA
GR-------------AFVKLLED-------SAVLHLGAEA-----------TDL-SLSLAKLT-DSEGRMEVKDLLFKMADSLQQLDSQGASS--------------------SFSPGKG
GD-------------LTVTLQNH-------KVLLTVGSGS----------NGAI-SYDLYEAR-ANEKKA LQRALFYFAENC ELEKRLAAKEEE ---------------- AS KKQ
GN-------------LTIAQVDG-------KVSLSVGA--------------SL-RYELYEAN-DYNQKAELQHVIFRMADAVSMLTHKLKVSSES-----------------FDRIRSD
GE-------------VSISGTGH-------RLQCTLGKGS-----------STL-TYDLYEAT-ASERKEDLKHILFRLADK TELDQKLSDST R ----------------LDALRQN
KN-------------LVLAELGR-------KMKLTLGRDT-----------QSI-DINLFEVT-AAIRKTELQAVIFRMADCISGLEASAEKDQQT ----------------IS LRQQ
GS------------IVNVSVTSS------SSLLLVLSSGG-----------RKI-DIELNKLP-ANDNREELKSLVFKLFDRITLLEEDLKDTKIQ-----------------LEEAKKS
ER------------DVHIALGGS------GQCIVKIQRPGAS---------DDL-VYQLETLH-GDDAVRQVQAVLLRMAEGTSSPLYNKTMDSLHDCRRQLLAAQQQAASSTLDTSF-D
SQ-------------VKGTVSPGR-----DTIQLQLPPLGSTPREVGNAMTEPV-VLQLNAVD-EGRGQVHLADMLMGIAQRCNDAVRRADRADAD-----------------LARARAG
dlYkrFilvLnekKtkIrslhnkllnaaqerekdikq
                       pFeensfleqFmieklpeaCsigdGkpFVmnLqdlYmaVTtqevqvgq
khllevq
PRPAG------------PQLFLPDPDP--------------QRGGPGPGVRRRCPGESLINPGFKSKKPAGGVDFDET
TQPAG-------------TQFLPELDH--------------QRGSSGPGVRRRCPGESLINPGFKSKKPAAGVDFDET
TPRSQ-------------QPILPDPSPRKNR----------AAGSALP-VKRKIPGESLINPGFKSKSVPSGVDFEDS
PGKSS----------SRSIFAAADLSPAKP-----------AAGSGQPLARKRLPGESLINPGFKRKKDPTGVDFEDP
SQVPQ-------------SLLFPDLDSRKK-----------GYGASASQLKKRLPGESLINPGSKSKKAARGVDFEEV
YQKRS-----------------AEFEPKKQ-----------HKGPVVAV-KKRLPGDSLINPGTKRKKPATGVAFDDE
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THRGL-----------YVPPSSTDLGGISST----------SSGRTNKL-LKP-AGHSLINPSTKKRKAASGVVFGDDDD
EDYTATLGTYA-----ADTHEDDDNDEGDHA----------SKRAHTSAPARKGGYRNLLNPSDRRRGKATGVQFDNTSSDSDSD
EGSGGGRHGGRYHRHTRPASEAFRDDDDDMLQAKSARDSAASASGMVAPPKRK-PGFSLINPSVQRRTAR-GVKFGASGDDGADE
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Fig. S1. Evolutionary analysis of PAXX. 
(A) Sequence alignment of XRCC4, XLF, SAS6 and PAXX orthologs. Structures of 
XRCC4, XLF and SAS6 (PDB codes: 1IK9 (7), 2QM4 (9), 2Y3W (zfSAS6) (10), 3PYI 
(ceSAS6) and 3Q0X (crSAS6) (11)) were aligned together with PAXX orthologs from 
various organisms, as indicated. Since the sequence of a PAXX homologue of 
Capsaspora was fused with the C-terminus of a predicted Co/Zn/Cd cation transporter in 
the NCBI database (NCBI Reference Sequence: XP_004364434.1), we concluded that 
M381 of the chimeric protein was the first methionine of the PAXX ortholog. The 
structural alignment is in JoY format (35) as indicated at the end of the alignment and the 
sequence alignment is represented in the Taylor color scheme. Secondary structure 
elements of the PAXX structure are shown above the alignment. PISA motifs and 
conserved tryptophans (see main text) are indicated by horizontal green and vertical black 
arrows, respectively. (B) A phylogenetic tree of PAXX orthologs,generated using 
TraceSuiteII (36). By using PSI-BLAST (37) followed by FUGUE searches (38), we 
identified PAXX homologs only in Filozoa, which includes animals and unicellular 
organisms such as choanoflagellates and the monotypic genus Capsaspora. 
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Fig. S2. PAXX is a dimer in solution. 
(A) Zigzag filament structure of PAXX. The coiled-coil of the PAXX homodimer (cyan 
and pink) is normal to and pointing out of the page in the left and right projections, 
whereas those of the other two dimers point in the opposite direction. (B) SAXS studies 
of PAXX1-145. Pink dots with error bars (grey) represent measured intensity and the black 
line in the scattering profile is calculated intensity from the crystal structure of PAXX1-145 
(χ=1.166). Inset shows an averaged DAMMIN model (grey) of PAXX1-145 together with 
the crystal structure. (C) Comparison of XRCC4-superfamily members focusing on 
closed and open conformations of the head-to-head interaction regions. PAXX, XRCC4, 
XLF and SAS6 are shown in cyan, silver, magenta and lime respectively. 
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Fig. S3. PAXX interacts directly with Ku. 
(A) Reciprocal GFP-pulldown from RPE-1 cells expressing GFP-tagged Ku70 from the 
endogenous XRCC6 locus showing that Ku70 interacts with PAXX. (B) WT C-terminal 
PAXX peptide, but not the V199A/F201A mutant, interacts with Ku. (C) Addition of 
PAXX177-204 peptide to cell lysate disrupts Ku-PAXX complexes in U2OS cells stably 
expressing the indicated GFP-PAXX protein where appropriate. (D) SPR of Ku-DNA 
and PAXX, showing that they interact with a Kd of 14.5 nM (assuming a 1:1 interaction 
between Ku-DNA and a PAXX homodimer). The direct interaction between Ku-DNA 
and PAXX1-204 was measured by comparing two channels immobilised Ku-DNA and 
DNA only in the presence of 0-80 nM of PAXXWT (left) or PAXXV199A/F201A (right). (E) 
SPR profiles of PAXX177-204 peptide competing with full-length recombinant PAXX for 
the Ku-DNA interaction. PAXX1-204 was added to immobilized Ku on DNA in the 
presence and absence of PAXX177-204 or PAXX177-V199A/F201A-204. 
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Fig. S4. PAXX localizes in the nucleus and PAXX-deficient cells are hypersensitive 
to IR. 
(A, B) PAXX is predominantly nuclear and does not localise to interphase or mitotic 
centrosomes. Interphase (A) and mitotic (B) images of HeLa cells transfected with 
plasmid encoding Flag-PAXX and immunostained with antibodies against Flag, γ-tubulin 
(centrosome marker) and DAPI (DNA dye). Magnified images in A (left) are single-
plane images of the area marked in white box. Projected image of 41 z-planes is shown in 
B. (C) Representative western blot showing efficiency of PAXX and XRCC4 depletion 
by siRNAs in the U2OS cells used in subsequent experiments. TopBP1 is a loading 
control. (D) PAXX depletion causes radiosensitivity similar to that caused by XRCC4 
depletion in clonogenic survival assays. Error bars represent the SEM from 3 independent 
replicates in this and subsequent experiments. 
Figure S5
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C
Clone Indel Indel sequence Size (nt) Predicted consequences for PAXX protein
1 del397-690
CTGTAGCTGTAGTCCTCCCATTGGCTAGGGCTCTGGGGTCGGGC
AGGTTTCGGGTGCCCCCAGTGGGCCTCGGGTTCCAGGCAGCTC
GTGACAAGCCCCTGTGCTCTCTAGAAAGCCCGTTTTGGCCTGAG
TGCGGCTGAGGACATCACCCCCCGGTTCAGGTGAGACCCAAGC
AGGGAGGAAGGACGGGTGGGGAGGAGGAGGGTCTGCCACAGC
TCTCCGCACCTCTCCTCTCCCAGGGCAGCCTGTGAGCAGCAAGC
TGTGGCTCTGACTCTGCAGGAGGACAGAGCATCC
294
Deletion causes frameshift and 
loss of PAXX residues after Leu60, 
assuming that the disrupted exon 
4 is spliced out
2 in679 TGGCTAGCTTGACTCTGCAGGAGTGGCTCTGTCCTCTGCAGGAG 44
Insertion causes frameshift after 
Glu91 and premature stop codon 
after 3 additional amino acids
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Fig. S5. Generation of PAXX-/- RPE-1 cells using CRISPR-Cas9. 
(A) Schematic representation of the C9orf142 gene targeting strategy. (B) Schematic 
representation of the C9orf142 gene targeting vector pMA-C9orf142. (C) Table 
summarizing the disruption of the second allele in 2 independent PAXX-/- cell clones. 
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Fig. S6. PAXX-deficient cells are hypersensitive to DSB-inducing agents and are 
defective in DSB repair. 
(A) Western blot confirming that PAXX expression is absent in PAXX-/- RPE-1 cells. 
XRCC4 is a loading control. In this and subsequent figures, “cl.” indicates clone number. 
(B) PAXX-/- RPE-1 cells are hypersensitive to phleomycin in clonogenic survival assays. 
(C) Representative western blot showing efficiency of PAXX, XLF and XRCC4 
depletion by siRNAs in PAXX+/+ and PAXX-/- RPE-1 cells used in subsequent 
experiments. (D) Clonogenic survival assay showing that PAXX-/- cells are radiosensitive 
and that PAXX loss is epistatic with XLF depletion. Note that this is the same experiment 
as shown in Fig. 3D of the main manuscript as both experiments were carried out 
concurrently. (E) Neutral comet assay showing that PAXX depletion in U2OS cells 
causes a similar DSB repair defect as that observed in XRCC4-depleted cells or PAXX-/- 
RPE-1 cells. (F) PAXX is required for NHEJ as measured by random plasmid integration 
in U2OS cells transfected with the indicated siRNAs. 
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Fig. S7. PAXX is not required for checkpoint signaling. 
(A) Western blots showing that induction of checkpoint signaling is similar in PAXX+/+ 
and PAXX-/- RPE-1 cells. (B) Western blots from U2OS cell extracts showing that 
checkpoint signaling is similar to control cells regardless of PAXX or XRCC4 status. 
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Fig. S8. PAXX interacts with Ku in vitro and does not affect overall levels of NHEJ 
factors. 
(A) Purified PAXX and Ku proteins. 2 µg of recombinant protein was loaded on each 
lane. “M” indicates protein ladder (kDa). (B) DNA-binding assays with recombinant 
PAXX. 100 ng of linearized pFastBacHTB plasmid was incubated with 1, 2, 3, 4 or 5 µg 
of PAXX1-204. Agarose gel was stained with SYBR gold. (C) EMSA of Ku and PAXX1-
204. 20 nM of Ku was added where indicated. The concentration of PAXX1-204 was 
increased sequentially 2-fold from 20 nM. For EMSA without Ku, 640 nM of PAXX1-204 
was added. (D) EMSA of Ku and PAXX1-204 with PAXX peptide. 20 nM of Ku and 200 
nM of PAXX1-204 were added where indicated. The concentration of PAXX177-204 was 
increased by 5-fold from 4 µM. (E) Whole cell extract controls for Fig. 4C in the main 
manuscript. 
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Fig. S9. Biophysical characterization of PAXX. 
(A) Monodispersity of PAXX1-145 in solution. Guinier plot of PAXX1-145 generated using 
ScÅtter shows the linearity (pink solid line) of observed intensity (blue circles) of the 
Guinier region of PAXX1-145. (B) The P(r) distribution function of PAXX1-145. (C) Fitting 
of SPR profiles of PAXX1-204 bound on Ku. Fitting curves (black) are overlaid over the 
SPR profiles of PAXX1-204 shown in Fig. S3D. 
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Table S1. 
Result of Back-Phyre search. Back-Phyre search (39) was carried out using the head 
domain of human XRCC4 (residues 1-118; PDB code: 1IK9). C9orf142 is highlighted in 
yellow. 
 
Rank Description Alignment 
Coverage 
Confidence % i.d. 
1 gi|4507945|ref|NP_003392.1| X-ray repair 
cross complementing protein 4 isoform 1 
[Homo sapiens] 
1-114 100 99 
2 gi|12408649|ref|NP_072044.1| X-ray repair 
cross complementing protein 
gi|12408649|ref|NP_072044.1| X-ray repair 
cross complementing protein 
1-114 100 99 
3 gi|12408647|ref|NP_071801.1| X-ray repair 
cross complementing protein 4 isoform 2 
[Homo sapiens] 
1-114 100 99 
4 gi|13376142|ref|NP_079058.1| XRCC4-like 
factor [Homo sapiens] 
30-103 80.5 20 
5 gi|29789058|ref|NP_056053.1| KIBRA protein 
[Homo sapiens] 
13-39 54.6 15 
6 gi|7662404|ref|NP_055774.1| caspase 
recruitment domain family, member 8 [Homo 
sapiens] 
14-47 36 15 
7 gi|48255889|ref|NP_002734.2| protein kinase C 
substrate 80K-H isoform 1 [Homo sapiens] 
3-45 35.6 16 
8 gi|39930541|ref|NP_899064.1| hypothetical 
protein LOC286257 [Homo sapiens] 
27-107 34.1 11 
9 gi|4507737|ref|NP_003314.1| tubby like protein 
2 [Homo sapiens] 
17-111 29.8 18 
10 gi|48255891|ref|NP_001001329.1| protein 
kinase C substrate 80K-H isoform 2 [Homo 
sapiens] 
3-45 28.6 16 
11 gi|4505525|ref|NP_002544.1| origin recognition 
complex subunit 5 isoform 1 [Homo sapiens]  
43-69 28 26 
12 gi|14249738|ref|NP_115909.1| N-
acetylglucosamine-1-phosphotransferase, 
gamma subunit [Homo sapiens] 
16497 25.1 12 
13 gi|19263349|ref|NP_597724.1| Cbp/p300-
interacting transactivator, with Glu/Asp-rich 
carboxy-terminal domain, 4 [Homo sapiens] 
47-82 20.9 15 
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Table S2. 
Result of FUGUE search of C9orf142.  Structures predicted to be certain homologues are 
highlighted in yellow. 
 
PDB code (chain) or protein family Z-score Certainty 
1IK9 (A) 8.28 CERTAIN 
1FU1 (A) 6.7 CERTAIN 
2QM4 (A) 4.67 LIKELY 
3AEI (A) 4.2 LIKELY 
1ZXA (A) 3.99 MARGINAL 
1WNL (A) 3.89 MARGINAL 
Fibrinogen C 3.3 GUESS 
2KRG (A) 2.9 GUESS 
3A2A (A) 2.85 GUESS 
2OSZ (A) 2.74 GUESS 
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Table S3. 
Statistics of X-ray diffraction data from crystals and structural refinement of PAXX 
constructs. 
 
Crystal PAXX1-145 PAXX1-166 PAXX1-204 
 Derivative 
KAu(CN)2 (Peak) 
Native Native 
X-ray Source Diamond Light Source, Beamline I03 
Wavelength (Å) 1.03961 0.97625 0.97625 
Resolution (Å) 45.52-2.46 55.20-2.35 24.47-3.45 
Space group P6522 
Unit Cell Parameters    
a=b  (Å) 91.04 91.95 89.58 
c (Å) 152.7 153.2 151.4 
β (°) 120 120 120 
Number of unique 
reflections 
14,219 16,230 4,986 
Completeness (%)  100 (100)a 98.5 (99.3) 97.3 (98.2) 
Redundancy 18.3 9.6 6.1 
bRsym (%)  4.0 (76.5) 5.2 (62.7) 8.8 (59.9) 
<I/σ> 40.4 (4.4) 24.3 (4.4) 9.1 (1.7) 
Phasing    
F.O.M. 0.311   
Overall score 49.85   
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Refinement    
PDB code  3WTD 3WTF 
Rcrystc (highest shell)  19.4 (23.0) 23.5 (36.6) 
Rfreed (highest shell)  22.9 (26.1) 26.8 (41.8) 
Number of atoms:    
Protein atoms  1970 1809 
Water molecules  97 3 
Average B-factors (Å2)  67.3 168.8 
Ramachandran favored (%)  97.7 97.6 
R.M.S.D.    
Bond (Å)  0.008 0.012 
Angle (˚)  1.131 1.642 
 
aThe statistics in parenthesis are for the highest resolution shell 
bRsym=Σh|Ih -<I>|/ΣhIh, where Ih is the intensity of reflection h, and <I> is the mean 
intensity of all symmetry-related reflections. 
cRcryst=Σ||Fobs|-|Fcalc||/Σ|Fobs|, Fobs and Fcalc are observed and calculated structure factor 
amplitudes. 
dRfree as for Rcryst using a random subset of the data (about 5% for PAXX1-145 and 10% for 
PAXX1-204) excluded from the refinement. 
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Table S4. 
ES-MS and SAXS studies of PAXX. 
 
Protein Rg (Å) Dmax 
(Å) 
Measured Mass by  
ES-MS (Da) 
Theoretical MW of 
monomer (Da) 
PAXX1-145 21.66 65 31216.4 ±0.6 15608.6 
PAXX1-204 N/A N/A 43566.4 ±1.7 21783.6 
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